secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0001437749-24-024947
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRC Health Q2 revenue $35M, EPS $0.26; amends credit; acquires NOBL Health
--------------------------------------------------------------------------

- Q2 revenue ~$35M vs ~$36M YoY; diluted EPS $0.26 vs $0.29 YoY; TRCV $138M at June 30.
- Credit agreement amended: maturity extended to May 2027; term loans bear SOFR+2.35% with 10-year amort.
- Acquired NOBL Health on July 15 for ~$6M cash + up to $1M earnout; NOBL had ~$2M TRCV.
- Board declared $0.12/share quarterly dividend, payable Oct 11, record Sep 27.
- ~1.1M shares remain under repurchase plan; no buybacks in Q2 pending amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774924024947/0001437749-24-024947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774924024947/nrc20240806_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-024947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer